news + events

Developed with J.P. Morgan and Johnson & Johnson Innovation, BioNJ’s Ninth Annual BioPartnering Conference will bring together more than 400 regional biopharmaceutical executives, investors, academic collaborators and business development professionals from the Northeast to Mid-Atlantic states for a day of networking, 1:1 partnering meetings, company presentations, exhibits and plenary sessions.

Apply today to be a company presenter and showcase your innovations to investors and business development professionals looking for new collaborations and partnerships. Limited slots available. There is no fee to apply or present. Deadline: March 27

Register by March 27 for the Early Bird Rate of $275 for BioNJ Members and $325 for Future Members. After March 27, the price will be $350 for BioNJ Members and $395 for Future Members. Contact Samantha Bamberger at 609.890.3185 or BioPartnering@BioNJ.org with questions.

More information >>>

Princeton Innovation Center BioLabs is proud to be a supporting partner of the BioNJ BioPartnering Conference.

Learn from an industry veteran on how to channel innovative science into novel medicines.

Princeton Innovation Center BioLabs and global pharmaceutical company Bristol-Myers Squibb (BMS) invite you to attend an exclusive speaking event featuring Dr. Miguel Sanjuan.

About Dr. Miguel Sanjuan
Dr. Miguel Sanjuan is a group director in the BMS Immuno-Oncology Small Molecule Biology Department. At BMS, Dr. Sanjuan leads a team of world-class immunologists with a proven record of discovering cancer treatments. Prior to joining BMS in 2017, Dr. Sanjuan worked at Medimmune (AstraZeneca) for eight years, where he led a team of twenty innovative scientists focused on the discovery of novel molecules for the treatment of autoimmune disorders. Previously, he worked as a staff scientist at St. Jude Children’s Research Hospital, where he discovered a novel intracellular mechanism that linked for the first time the cellular self-digestion pathway, autophagy, with the elimination of extracellular pathogens. His cutting-edge research has collectively led to peer-reviewed publications, in journals such as Nature, Nature Immunology, Immunity, and the Proceedings of National Academy of Sciences, USA (PNAS).

Dr. Sanjuan received a bachelor’s degree in biology from the University of Seville and a doctorate in molecular biology from the Autonomous University of Madrid. He then trained as a postdoc fellow at Johnson & Johnson.

Schedule
Networking: 5:30–6 p.m.
Presentation: 6 p.m.

Join us for a lunch presentation on insurance for emerging businesses courtesy of CBIZ, Inc., one of the nation’s leading providers of professional advisory services. Startups will learn

• common exposures for startups
• potential insurance solutions
• when and why specific coverages are needed
• what Directors and Officers Liability Insurance is and its importance

RSVP to Michelle Roemer-Schoen no later than Friday, April 12. 

Dr. Young-Jack Lee, president and founder of LSK Global, South Korea’s largest local contract research organization (CRO), will present a Lunch & Learn hosted by Princeton Innovation Center BioLabs and Fox Rothschild LLP.

Dr. In-Jin Jang, director at the Clinical Trials Center of Seoul University Hospital, one of the leading clinical trial centers in the world, will join Dr. Lee for the discussion. 

Lee and Jang will discuss the state of clinical trials and drug sponsorship in east Asia and the United States, including the unique opportunities available for drug sponsors and CROs who are able to leverage the benefits of efficient management of cross-border clinical trials. They will discuss and welcome questions on the state of Korean clinical trials in both the United States and Korea, informed by Dr. Lee’s experience working at the National Institutes of Health and the National Cancer Institute, both based in Bethesda, Maryland.

The presentation will also discuss the importance of building relationships between Korea and the U.S., which in turn improves the efficiency of the regulatory approval process for clinical trials.

The Lunch & Learn is ideal for universities, pharmaceutical and medical device clients, contract research organizations, investors and venture capital groups, anyone involved in work related to clinical trials and associated research.

Pictured: Dr. Young-Jack Lee

Jim Gunton, managing partner and founder of Tech Council Ventures, an early stage venture capital investment firm, will speak on the topic of networked capital. 

He has invested in privately-held growth technology companies for more than twenty years. Before cofounding in 2001 the $80 million NJTC Venture Fund, Gunton was a partner at Edison Venture Fund and a manager at Oracle Corporation in the Silicon Valley. He served formerly as a governor of the National Association of Small Business Investment Companies. He has served on the board of numerous private and public companies including Achieve3000, Amber Road (NYSE: AMBR), CytoSorbents (NASDAQ: CTSO), InstaMed, IntegriChain, and CareGain.  

Schedule
Networking: 5:30–6 p.m.
Talk: 6:00 p.m. 

Are you a biotech entrepreneur? Have you created a startup and would like more information about accounting and tax planning? Join our specialists from EisnerAmper, LLP for one-on-one discussions about accounting and tax planning for you and your company. Some of the topics you might consider taking advantage of during these meetings are:  

• Year-end tax planning
• Research and development credits
• Using research and development credits to reduce payroll tax expenses
• Cash basis vs. accrual basis tax reporting
• QuickBooks and other accounting software assistance
• Maximizing personal retirement contributions
• Entity structuring and ownership issues

Call us at 609.423.1540 to set up your appointment today!

EisnerAmper, LLP Specialists 
Tim O’Rourke is a partner in EisnerAmper’s Private Business Services Group. With more than twenty-five years f experience, Tim consults with clients regarding corporate and individual income tax planning, accounting, financial statement preparation, financial analysis, and business and personal financial planning. 

Charles Saydek is a senior manager in EisnerAmper’s Private Business Services Group. Charles has more than fifteen years of experience in public accounting, where he has specialized in business consulting, reviews, compilations, tax services, and retirement plan audits. 

Brian Trelstad, a partner at Bridges Fund Management based in New York City, will speak on the topic of impact investing.

Trelstad has more than ten years of impact investment experience, having served until 2012 as the chief investment office of Acumen Fund, where he oversaw $55m of investments into companies that were delivering health, water, energy, and agriculture services to economic base of the pyramid in South Asia and Sub-Saharan Africa.

He was a cofounding board member of the Aspen Network of Development Entrepreneurs and was one of the principal architects of impact management software tool, Pulse, and the Impact Reporting and Investment Standards. Prior to Acumen Fund, Trelstad worked as a consultant at McKinsey & Company, was a lead environmental staff person at the Corporation for National and Community Service, and was involved in a range of nonprofit and for-profit start ups.

Trelstad is an Entrepreneur in Residence with the Keller Center at Princeton University.

Schedule
Networking: 6–6:30 p.m.
Talk: 6:30 p.m.

Cofounder and Executive Chairman Dr. Steve Sun grew GENEWIZ, a leading global genomics service provider, from a two-person biotech startup to an international operation employing more than 1,000 people across 12 facilities around the world. GENEWIZ was acquired in September for $450 million.

Sun will share his GENEWIZ story, followed by a Q&A.

Schedule 
5:30–6:00 p.m., Networking
6:00 p.m., Fireside Chat

This is a collaborative event by the Commercialization Center for Innovative Technologies (CCIT) and Princeton Innovation Center BioLabs. For more information on CCIT, contact Lenzie Harcum. For more information on Princeton Innovation Center BioLabs, contact Nishta Rao.

Geoff Yang, cofounder of Redpoint Ventures and founder and principal of LaneOne, will discuss trends in tech investing. 

Yang has backed companies since their founding including, Arista, Ask.com, Bluefin, Calix, Efficient Frontier, Foundry Networks, Excite, Juniper Networks, Machinima, MySpace, and TiVo. He currently serves on the boards of Redpoint portfolio companies Electric Imp, Scribd, TasteMade, and Victorious; as well as AT&T, Esquel Group, and Franklin Resources (Franklin Templeton Funds). 

Currently chair of the Princeton Entrepreneurship Council Alumni Advisory Board, Yang has served as director of the National Venture Capital Association, president of the Western Association of Venture Capitalists, and a member of the President’s Information Technology Advisory Committee for the United States. He has also served as a member of the Advisory Council for the Stanford Graduate School of Business, chairman of the Stanford Engineering Venture Fund, 

He holds a BSE in engineering from Princeton University and an MBA from Stanford University.

Join us for a lunch presentation on precise methods in cell counting courtesy of ChemoMetec A/S. Learn about how easy it is to count cells on the NucleoCounter NC-200 and how it can help you standardize cell counting as your company grows.

This is a residents only event. 

On Wednesday, November 28, Princeton Innovation Center BioLabs will be awarded the "Innovator of the Year" award by the Princeton Regional Chamber of Commerce at its 2018 Annual Business Leadership Awards Gala.

Program Includes:

• Keynote by Dr. Donald C. Lo, NIH National Center for Advancing Translational Sciences 
• Case studies by Dr. Troy Messick, Wistar Institute, and Dr. Scott Kachlany, Rutgers University
• Dr. Bob DeVita Mount Sinai School of Medicine
• Dr. Krishnan Viswandham, vice president, BD & Global Alliances, Celgene Corporation
• Poster session
• Networking opportunities

Presented by the New Jersey Academic Drug Discovery Consortium.

Mike Wiley, vice president at New Jersey Health Foundation & Foundation Venture Capital Group, will discuss his organization’s impact investing funding model. He will also cover other impact-oriented investment models and sources of capital that entrepreneurs may want to consider to support the development and growth of their startups.

This is the first in a series on venture funding presented by Princeton Entrepreneurship Council.

New Jersey BioBreak is an invite-only group that holds regular networking events for life science executives. Their 1,200 active members share a common desire in building the New Jersey region into a thriving innovation hub. Their membership is a blend of pharmaceutical executives, entrepreneurs, academic researchers, and investors.

Attendance is free of charge for registered BioBreak members. There will be light appetizers and an open bar for each person who RSVPs prior to the event. 

A Science Panel Presented by BioLabs@CIC Philadelphia

Immunotherapy, or harnessing the body’s immune system to eliminate or slow the spread of disease, has the potential to upend conventional approaches for treating patients. Early results show improved outcomes and survival rates for people with certain types of cancers, leading to hopes that new drugs working in concert with the immune system may ultimately replace radiation and chemotherapy.

The panel will give their views on the promise of immuno-oncology, focusing on therapies and technologies now emerging from research labs.

Featured speakers include: 

• Peter Melley, director, New Ventures, University City Science Center (moderator)
• Dora Mitchell, PhD, vice president, operations, Carisma Therapeutics
• Dr. Ken Hance, senior director and head of immune biology, Immuno-Oncology and Combinations Discovery Performance Unit (IOC DPU), GlaxoSmithKline
• Matthew Cohen, principal, Osage University Partners
• Melina Blees, site director, BioLabs@CIC Philadelphia

The event is free and open to the public. Space is limited, so be sure to register now. 

BioNJ, the life sciences trade association for New Jersey, is offering a complimentary, one-year membership to resident life sciences companies in the Princeton Innovation Center BioLabs. The lunch & learn will offer an opportunity to learn about membership benefits associated with BioNJ, including cost savings programs, networking, along with access to talent and educational development programs.

This is a “Residents Only” event.

Join BioSapien for a 3D printing demonstration. Samples limited to one per company.

This is a “Residents Only” event. 

TechLaunch is shaking things up with a new, open/participatory model to replace the traditional investor pitch in which the startup is sequestered after pitching so that the panel can debate the merits of investing, behind closed doors. Instead, everything and everybody stays in the room. This way, all attendees will benefit from:

• Networking with other entrepreneurs & investors
  
• Hear live feedback to presenting startups
  
• Witnessing a mentored and vetted investor pitch
  
• Participating in the interaction between startups & investors

A presentation on Intellectual Property for emerging companies.

Muriel Liberto and Sean Grygiel from Mintz Levin will discuss all aspects of intellectual property including trademark, copyright, patents, and trade secrets and how IP can be a valuable business asset when developed early with a business focused strategy.

Program:

5:00 - 6:00pm — Check-in, Hors D'Oeuvres, Networking
6:00 - 7:00pm — Presentation and Discussion
7:00 - 7:45pm — Networking

Please register to let us know you are coming.

Princeton University and BioLabs are pleased to announce the Ribbon Cutting Ceremony and Reception at Princeton Innovation Center BioLabs

We look forward to developing an inclusive technology and life science startup ecosystem in central New Jersey.

Ribbon Cutting at 1:00 pm

BioNJ’s Eighth Annual BioPartnering Conference will take place at The Palace at Somerset Park, Somerset, New Jersey on Thursday, May 3rd.

The conference, which is developed in partnership with J.P. Morgan, brings more than 300 regional biopharmaceutical executives, investors, academic collaborators and business development professionals for a day of networking, 1-1 partnering meetings, company presentations, exhibits and plenary sessions.

Are you an entrepreneur? Do you want to change the world?

An exclusive preview of our NASA Collaborative National Event Series for 52 Ambitious Princeton Area HS Students.

A unique learning experience by Fizzee Labs:

- Complete in a game that builds your Innovation IQ
- Learn how successful entrepreneurs think and activate

Grand Prize:

13 Competitors will earn a spot in the NJ statement Tournament

Keynote Begins: 1pm

Keynote Speaker: Greg Olsen is an American scientist and entrepreneur, space tourist, and Princeton University Entrepreneur in Residence.

“How to get Funded” Series

Bert Marchio – Edge Therapeutics’ Chief Accounting Officer – talks about how they used state funding programs to grow Edge Therapeutics from startup to IPO.
Kamran Hashmi – NJ EDA – talks about the different state funding programs and what might be right for your company.

BioNJ’s Annual Dinner Meeting & Innovation Celebration, which is also the group's 25th anniversary, will take place on February 1, 2018.

Panel
Edward Bukstel - CEO, Clinical Blockchain
Soraya Ghebleh - Attorney - Hogan Lovells
Evin McMullen - Product Lead, Linnia / ConsenSys
Michael Sena - Product Head, uPort

Moderator
Ramesh Babu - Practice Head - FS Analytics and Blockchain, Wipro

Please join us for a media tour of the Princeton Innovation Center Biolabs, the newest effort by Princeton University to promote innovation and to support and grow the regional entrepreneurial ecosystem. This preview will include presentations by Johannes Fruehauf, Co-Founder and CEO of Biolabs, and Paul LaMarche, Vice Provost, Space Programming and Facilities at Princeton University, and Chairman of the Princeton Innovation Center, LLC.

The Princeton Innovation Center Biolabs, operated by Biolabs (headquartered in Cambridge, Massachusetts) provides co-working spaces specifically designed to meet the needs of the highest-potential science startups. The Center is available to companies formed by faculty, students and alumni, as well as by members of the wider New Jersey community. Located at Princeton Forrestal Center, the 31,000-square foot incubator offers a variety of shared space such as wet labs for chemical, biological and pharmaceutical development and dry lab space for engineering development, as well as shared office and desk space for resident companies and related ventures. The Center, which opened this month, is equipped with a broad array of premium scientific equipment and will offer additional services and amenities for resident companies.

The newly renovated space is strategically designed to promote collaboration and help startups go further and faster on limited investment capital, enabling a potentially shorter path from proof-of-concept to commercialization. Princeton Innovation Center Biolabs will also host regular educational programming and community networking events. There is ample free parking available.

Media Contacts
Princeton: Michael Hotchkiss, mh14@princeton.edu
Biolabs: Caroline Grossman caroline@biolabs.io

Please RSVP by noon Wednesday, Jan 24th, to Michael Hotchkiss:

Health 2.0's Diversifying Digital Health event will take place at The Farm in Soho, New York, NY on January 22, 2018.

Join this event to dig into the topic of diversity in the digital health space. The goal of this meet-up is to foster an honest and frank discussion about how we can create diverse workplaces and develop inclusive technology for the people we serve.

The 2018 Small Business Contracts & Capital Sourcing Expo is taking place at Rutgers, Newark, NJ on January 12, 2018 from 8:00am - 1:00pm.

This is a business-to-business-to-consumer networking event. Entrepreneurs and small businesses are given an opportunity to market, promote and sell their products or services to a diverse audience. The Expo is a great way to increase sales and directly market to consumers.

There will be a Holiday Networking Event hosted by Princeton Tech Meetup on December 14, 2017 from 6:30pm - 8:45pm at the Princeton Public Library (Community Room - 1st Floor).

There will be expanded food and refreshments, and most of the floor will be open for networking. Around the perimeter of the room, we will have booths set up for sponsors and selected members to demo their products and services.

New Jersey Entrepreneurial Network's Company Valuations From An Entrepreneurs And An Investors Viewpoint will take place at TigerLabs, 232 Nassau Street, Princeton, NJ on December 13 from 5:00pm - 8:00pm.